Autoverification of Clinical Laboratory Test Results (AUTO10-A); IT Security of In Vitro Diagnostic Instruments and Software Systems (AUTO11-A); Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures (EP10-A3); Viral Culture (M41-A)

EP10-A3—Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures; Approved Guideline—Third Edition
This guideline provides experimental design and data analysis for preliminary evaluation of the performance of a measurement procedure or device.
Purchase here.

M41-A—Viral Culture; Approved Guideline
This document provides guidance for viral culture and identification procedures performed in the clinical virology laboratory.
Purchase here.

Second Notice

AUTO10-A—Autoverification of Clinical Laboratory Test Results; Approved Guideline
This document provides a general framework that will allow each laboratory to easily design, implement, validate, and customize rules for autoverification (automated verification) based on the needs of its own patient population.
Purchase here.

AUTO11-A— IT Security of In Vitro Diagnostic Instruments and Software Systems; Approved Standard
This document provides a framework for communication of IT security issues between the IVD system vendor and the healthcare organization.
Purchase here.

Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

You may automatically receive or select approved-level documents as a member benefit.  Find out more about joining CLSI:  view membership options and benefits. [ return to top ]